NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,997 | +122.9% | 1,519 | +128.8% | 0.00% | – |
| Q2 2023 | $4,933 | -55.0% | 664 | -58.0% | 0.00% | – |
| Q1 2023 | $10,963 | +45.5% | 1,582 | +115.8% | 0.00% | – |
| Q4 2022 | $7,535 | -24.6% | 733 | +21.6% | 0.00% | – |
| Q3 2022 | $10,000 | -67.7% | 603 | +2.6% | 0.00% | – |
| Q2 2022 | $31,000 | -42.6% | 588 | -19.8% | 0.00% | – |
| Q1 2022 | $54,000 | -88.8% | 733 | -78.3% | 0.00% | -100.0% |
| Q4 2021 | $483,000 | +475.0% | 3,377 | +742.1% | 0.00% | – |
| Q3 2021 | $84,000 | +75.0% | 401 | +78.2% | 0.00% | – |
| Q2 2021 | $48,000 | +585.7% | 225 | +462.5% | 0.00% | – |
| Q1 2021 | $7,000 | -87.7% | 40 | -92.2% | 0.00% | – |
| Q4 2020 | $57,000 | 0.0% | 515 | -1.9% | 0.00% | – |
| Q3 2020 | $57,000 | +5600.0% | 525 | +162.5% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |